Disease-modifying drugs in rheumatoid arthritis

Practitioner

Volumn 245, Issue 1629, 2001, Pages 1018-1024

  Rahman, Anisur ^a   Ahmed, Salma ^a   Underwood, Martin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTI INFLAMMATORY AGENTS, NON STEROIDAL; ANTIRHEUMATIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; FEMALE; HUMAN; MALE; PAIN; PATIENT SELECTION; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMAN; MALE; MIDDLE AGE; PAIN; PATIENT SELECTION; PROGNOSIS;

EID: 0035656665     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Wollheim FA. Rheumatoid arthritis -the clinical picture. In: Oxford Textbook of Rheumatology (2nd edition). Eds Maddison PJ, Isenberg DA, Woo P, Glass DN. OUP, Oxford 1998: Chapter 5.4.2
2. Green M, Marzo-Ortega H, McGonagle D et al. Persistence of early inflammatory arthritis -the importance of disease duration, rheumatoid factor and the shared epitope. Arthritis Rheum 1999;42:2184-2188
3. Van der Heijde DMFM, van Leeuwen MA, van Riel PLCM et al. Biannual radiographic assessments of hands and feet in a three-year prospective follow-up of patients with early rheumatoid arthritis. Arthritis Rheum 1992;35:26-34
4. Felson DT, Anderson JJ, Meenan RF. Use of short-term efficacy/toxicity trade-offs to select second-line drugs in rheumatoid arthritis - a meta-analysis of published clinical trials. Arthritis Rheum 1992;35:1117-1125
5. Silman A, Shipley M. Ophthalmological monitoring for hydroxychloroquine toxicity: a scientific review of the available data. Br J Rheumatol 1997;36:599-601
6. Smolen JS, Kalden JR, Scott DL et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised multicentre trial. European Leflunomide Study Group. Lancet 1999;353:259-266
7. Emery P, Breedveld FC, Lemmel EM et al. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Multinational Leflunomide Study Group. Rheumatology 2000;39:655-665
8. British Society for Rheumatology. National guidelines for the monitoring of second-line drugs (2nd edition). British Society for Rheumatology, London: 2000